» Articles » PMID: 11264478

Molecular Basis of Ethnic Differences in Drug Disposition and Response

Overview
Publisher Annual Reviews
Specialties Pharmacology
Toxicology
Date 2001 Mar 27
PMID 11264478
Citations 146
Authors
Affiliations
Soon will be listed here.
Abstract

Ethnicity is an important demographic variable contributing to interindividual variability in drug metabolism and response. In this rapidly expanding research area many genetic factors that account for the effects of ethnicity on pharmacokinetics, pharmacodynamics, and drug safety have been identified. This review focuses on recent developments that have improved understanding of the molecular mechanisms responsible for such interethnic differences. Genetic variations that may provide a molecular basis for ethnic differences in drug metabolizing enzymes (CYP 2C9, 2C19, 2D6, and 3A4), drug transporter (P-glycoprotein), drug receptors (adrenoceptors), and other functionally important proteins (eNOS and G proteins) are discussed. A better understanding of the molecular basis underlying ethnic differences in drug metabolism, transport, and response will contribute to improved individualization of drug therapy.

Citing Articles

Pharmacokinetics, Pharmacodynamics, and Safety Evaluation of the Novel HIF-PH Inhibitor Enarodustat: An Open-Label Phase I Study in Healthy Chinese Participants.

Cui C, Niu X, Li H, Zhang R, Geng L, Lin W Clin Drug Investig. 2025; .

PMID: 40074970 DOI: 10.1007/s40261-025-01428-9.


The role of candidate pharmacogenetic variants in determining valproic acid efficacy, toxicity and concentrations in patients with epilepsy.

Yazbeck H, Youssef J, Nasreddine W, El Kurdi A, Zgheib N, Beydoun A Front Pharmacol. 2024; 15:1483723.

PMID: 39539630 PMC: 11558073. DOI: 10.3389/fphar.2024.1483723.


Enhancing voriconazole therapy in liver dysfunction: exploring administration schemes and predictive factors for trough concentration and efficacy.

Zhao Y, Liu H, Xiao C, Hou J, Zhang B, Li J Front Pharmacol. 2024; 14:1323755.

PMID: 38239188 PMC: 10794455. DOI: 10.3389/fphar.2023.1323755.


Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review.

Roberts B, Cooper Z, Lu S, Stanley S, Majda B, Collins K Front Pharmacol. 2023; 14:1267294.

PMID: 37795032 PMC: 10545970. DOI: 10.3389/fphar.2023.1267294.


Sustained beneficial effect of β-blockers on clinical outcomes after discontinuation in patients with ST elevation myocardial infarction.

Park J, Seo K, Choi S, Yoon M, Hwang G, Tahk S Medicine (Baltimore). 2023; 102(37):e35187.

PMID: 37713877 PMC: 10508429. DOI: 10.1097/MD.0000000000035187.